On March 10, 2021, the United States Trade Representative (USTR) published an extension of the COVID-19 related medical-care and response product exclusions from Section 301 duties covering imports from China. The agency determined it would be inappropriate to allow the exclusions to lapse in consideration of the ongoing efforts to combat the COVID-19 pandemic. The
Latest Post
More Posts
U.S. Importers Should Reevaluate “First Sale” Customs Programs
Commerce Department Seeks Comments on Section 232 Exclusion Process for Steel and Aluminum
Commerce Launches 232 Investigations on Transformer Components and Mobile Cranes
Step Right Up: Opportunity to Shape new UK Tariff Policy
The United States and India Set to Complete Limited Trade Deal
What’s In the “Phase One” Agreement with China and What Comes Next?
United States and China Finally Agree to “Phase One” Deal
Congress Passes Hong Kong Human Rights and Democracy Act
EU Traders’ Holiday Cheer in Short Order
Subscribe: Subscribe via RSS
Firm/Org